Core Insights - Klarna Group PLC's "buy now, pay later" model is facing challenges in the public market, with a significant focus on losses despite reporting a record revenue quarter [1] - The company reported a 38% year-over-year revenue increase to $1.08 billion, but also experienced a quarterly loss of $26 million, leading to a stock selloff [1][4] - Legal pressures are mounting, with a deadline for investors to seek lead plaintiff status in a securities class-action lawsuit related to IPO disclosures [2][5] Revenue and Financial Performance - Klarna's revenue growth is overshadowed by rising credit quality concerns, as provisions for loan losses have surged alongside increased lending activities [3] - The company projected first-quarter revenue below analyst expectations, raising concerns about potential growth slowdown [3] Market Reaction - Following the earnings release, Klarna's shares dropped as much as 25%, reflecting investor concerns over profitability and credit exposure [4] Legal Challenges - A securities lawsuit alleges that Klarna did not fully disclose risks associated with loan losses and credit reserves in its IPO filings, with a critical deadline approaching for investors [5] IPO Context - Klarna went public in September 2025 at $40 per share, but the stock has since fallen to around $14 per share due to rising credit losses and weaker guidance [6] User Growth and Market Dynamics - Despite the financial challenges, Klarna reported strong user growth, with active consumers reaching 118 million and gross merchandise volume at $38.7 billion [7] - The shift from profitability to loss, combined with rising credit costs and ongoing litigation, has altered the narrative surrounding the company's post-IPO performance [7]

Group 1 - The law firm Faruqi & Faruqi, LLP is investigating potential claims against REGENXBIO Inc. related to a federal securities class action due to alleged violations of federal securities laws [1] - The complaint alleges that REGENXBIO and its executives made false or misleading statements and failed to disclose material adverse facts regarding the efficacy and safety of its RGX-111 trial study [1] - On January 28, 2026, REGENXBIO announced that the FDA placed a clinical hold on its RGX-111 investigational gene therapy for MPS I after a case of neoplasm was reported in a participant [1] - The FDA also placed a clinical hold on RGX-121 for MPS II, citing similarities in products and shared risks between the clinical studies [1] - Following the FDA's announcement, REGENXBIO's stock price fell by $2.40 per share, or 17.9%, closing at $11.01 per share [1] Group 2 - The deadline for investors to seek the role of lead plaintiff in the class action is April 14, 2026 [1] - Any member of the putative class can move the Court to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [1] - Faruqi & Faruqi encourages individuals with information regarding REGENXBIO's conduct to contact the firm, including whistleblowers and former employees [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Klarna Group plc due to allegations of violations of federal securities laws related to misleading statements and inadequate disclosures regarding loss reserves following its IPO [2][4]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses exceeding $100,000 in Klarna to contact them for discussing legal options [1]. - A federal securities class action has been filed against Klarna, with a deadline of February 20, 2026, for investors to seek the role of lead plaintiff [2][6]. - The complaint alleges that Klarna and its executives materially understated the risk of increased loss reserves shortly after the IPO, which led to misleading public statements [4]. Group 2: Financial Performance and Market Reaction - Klarna reported a net loss of $95 million in its first earnings report since going public, with provisions for loan losses amounting to $235 million, exceeding analyst estimates of $215.8 million [5]. - The provisions for loan losses represented 0.72% of gross merchandise volume, an increase from 0.44% the previous year [5]. - Following the earnings report, Klarna's stock experienced a decline of 9.3% on November 18, 2025 [5].

Core Insights - Klarna's banking customer base doubled over the past year, reaching 15.8 million, representing a 101% year-over-year growth [2] - The company reported a net loss of $26 million for the fourth quarter and a total net loss of $273 million for the year, with shares dropping significantly [8][9] Financial Performance - Revenue increased by 38% year over year to $1.082 billion, marking Klarna's first quarter exceeding $1 billion [10] - Gross merchandise volume (GMV) grew by 32% year over year to $38.7 billion [10] - The number of active customers rose by 28% to 118 million, and the number of merchants increased by 42% to 966,000 [10] Customer Engagement - The number of active card users surged by 288% year over year to 4.2 million [3] - Fair Financing GMV grew by 165% year over year to reach $4.5 billion [3] - Consumer deposits increased by 37% to $13 billion [3] Strategic Initiatives - Klarna is focused on transforming its cost structure through AI-enabled productivity, having reduced headcount by 49% and operating expenses by 8% over the past three years while growing revenue by 104% [11] - The CEO emphasized that banking customers generate three times more revenue per user compared to base customers, highlighting the importance of deepening consumer relationships [8]

Core Insights - Klarna reported revenue of $1.08 billion for the quarter ended December 2025, showing no change year-over-year, with an EPS of -$0.12 compared to $0 in the previous year [1] - The revenue exceeded the Zacks Consensus Estimate of $1.07 billion by +0.76%, while the EPS fell short of the consensus estimate of -$0.03 by -359.77% [1] Performance Metrics - Klarna had 118 million active users, surpassing the average estimate of 117.08 million from two analysts [4] - The Gross Merchandise Volume (GMV) was reported at $38.7 billion, exceeding the average estimate of $38.05 billion [4] - Interest income revenue was $267 million, slightly above the average estimate of $263.55 million [4] - Transaction and service revenue was $743 million, below the average estimate of $756.47 million [4] Stock Performance - Klarna's shares have declined by -30.8% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Viewpoint - Klarna's shares fell nearly 25% after reporting a larger-than-expected net loss in Q4, despite achieving its first $1 billion revenue quarter [1][5]. Financial Performance - For Q4, Klarna reported a net loss of $26 million, or $0.19 per share, compared to Wall Street's expectation of a $0.02 loss, marking a significant decline from a $40 million profit in the same quarter last year [2]. - Revenue grew 38% year-over-year to $1.082 billion, slightly exceeding analysts' estimates of $1.07 billion [3]. - Adjusted operating profit for the quarter was $47 million [4]. Growth Metrics - Active Klarna consumers increased by 28% to 118 million, while the number of merchants using the platform grew by 42% to 966,000 [4]. - Gross merchandise volume (GMV) rose 32% to $38.7 billion [4]. - US revenue surged 58% year-over-year, driven by the adoption of Fair Financing offerings [3]. Strategic Outlook - Klarna's CEO emphasized the company's goal of building a global digital bank that enhances consumer control over finances, highlighting the strong demand for its services [5]. - The company reported early progress in subscription offerings, with 3.5 million subscriptions currently in trial periods, expected to contribute to future monetization [4].

Core Viewpoint - Klarna Group plc is facing a securities class action lawsuit for allegedly failing to disclose material information in its registration statement related to its September 2025 IPO, which has led to investor losses [3]. Group 1: Lawsuit Details - The lawsuit, titled Nayak v Klarna Group Plc., et al., is pending in the United States District Court for the Eastern District of New York [4]. - Klarna and certain executives are accused of materially understating the risk of increased loss reserves shortly after the IPO, which they either knew or should have known [3]. - The lawsuit claims that the public statements made by the defendants were materially false and misleading, resulting in damages to investors when the true information became public [3]. Group 2: Legal Actions and Deadlines - Investors who purchased Klarna securities have until February 20, 2026, to file lead plaintiff applications in the class action lawsuit [1]. - Interested parties can contact Kahn Swick & Foti, LLC for discussions regarding their legal rights and potential recovery for economic losses [2].

因高速增长推高成本，瑞典先买后付平台Klarna由盈转亏，股价下跌23%。 来源：滚动播报 ...

每经AI快讯，2月19日，Klarna股价下跌23%。 ...

Core Viewpoint - Klarna Group plc is facing a federal securities class action lawsuit due to allegations of misleading statements regarding its financial health and risk management practices, particularly related to its loss reserves following its IPO in September 2025 [1][1]. Summary by Relevant Sections Legal Action - Faruqi & Faruqi, LLP is investigating potential claims against Klarna and reminds investors of the February 20, 2026 deadline to seek the role of lead plaintiff in the class action lawsuit [1][1]. - The lawsuit claims that Klarna executives materially understated the risk of increased loss reserves shortly after the IPO, which they should have been aware of given the risk profile of borrowers [1][1]. Financial Performance - Klarna reported a net loss of $95 million in its first earnings report since going public, while setting aside $235 million for loan loss provisions, exceeding analyst estimates of $215.8 million [1][1]. - The provisions for loan losses represented 0.72% of gross merchandise volume, an increase from 0.44% a year ago [1][1]. - Following the release of this financial information, Klarna's stock price fell by 9.3% on November 18, 2025 [1][1].